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Deferoxamine confers striking protection against cold storage
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Byproducts of oxidant tissue stress, most notably malondialde-
hyde (MDA) and Schiff bases, have been documented in renal
tissues following cold storage (CS) and subsequent transplanta-
tion (such as [1—3]). While the exact nature and the source(s) of
the responsible free radicals remain unclear, it is widely assumed
that they are generated during the early reperfusion period [4, 5].
CS may help "set the stage" for this early reperfusion oxidant
attack. As examples: (1) ATP breakdown to hypoxanthine during
CS may fuel xanthine oxidase-mediated reperfusion oxidant stress
[6]; (2) CS associated changes in plasma membrane phospholipids
and arachidonate availability could predispose to subsequent lipid
peroxidative damage [3, 5]; and (3) since tissue injury can liberate
iron from intracellular binding sites [7, 8], iron catalyzed oxidant
injury during reperfusion could result. Free iron can amplify
diverse forms of tissue damage, suggesting that this could be a
particularly important injury pathway [9].
These considerations have prompted past explorations of
whether iron chelation therapy (such as with deferoxamine),
administered at the time of tissue harvesting and re-implantation,
improves post-transplant kidney function. While it is clear that
such therapy can decrease lipid peroxidation [1—5], no clear
evidence for improved tubular cell integrity has been provided [1,
3, 10, 11]. This may be due to the fact that these studies have
primarily assessed protection by direct or indirect assessments of
GFR, performed in small numbers of animals. Since a panoply of
factors can impact on GFR in addition to structural tubular
integrity (such as glomerular hemodynamics), a cytoprotective
effect expressed directly at the proximal tubule could easily have
been missed. Therefore, the present study has sought to clarify
whether iron chelation can specifically protect proximal tubular
cells from CS injury. To achieve this end, proximal tubular
segments (PTS) were harvested from mouse kidneys, and they
were subjected to 22 hours of CS in the presence or absence of an
iron chelator, deferoxamine (DFO). Cellular integrity was deter-
mined immediately after CS and during a subsequent two-hour
37°C re-oxygenation period.
Male CD-i mice (—25 g; Charles River Laboratories, Wilming-
ton, MA, USA), housed under standard vivarium conditions, were
anesthetized with pentobarbital (—2 mg i.p.), the kidneys were
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removed, and PTS were isolated as previously described [12]. In
brief, the cortices were cooled, dissected, minced, digested with
collagenase, passed through a stainless steel sieve, and pelleted.
Viable PTS were recovered by centrifugation through 32% Per-
coIl. After multiple washings, the recovered PTS were suspended
in 1.5 ml of University of Wisconsin cold storage solution (——4 to
8 mg PTS protein/mi). The preparations were then split into
halves. DFO was added to one half (final concentration, 2 mM);
the remaining half served as a paired control (no DFO). The
samples were allowed to pellet by gravity and were immediately
stored at 4°C for 22 hours. At the end of CS, the samples were
gently re-suspended, a sample was removed to determine %
lactate dehydrogenase (LDH) release as a marker of cell viability
[12], and then they were washed by adding 15 ml of an incubation
buffer (see below), followed by centrifugation. The pelleted
tubules were re-suspended in 1.5 ml of incubation buffer [in
mmol/liter: NaCl, 100; KC1, 2.1; NaHCO3, 25; KH2PO4, 2.4;
MgSO4, 1.2; MgCl2, 1.2; CaCI2, 1,2; glucose, 5; alanine, 1; Na
lactate, 4; 10 Na butyrate; dextran, 0.6%; gassed with 95% 02/5%
CO2 (02/C02); pH 7.4]. They were transferred to 10 ml Erlen-
meyer flasks, re-gassed with 02/C02 and placed in a 37°C shaking
water bath. Samples were removed at the start of the incubation
and 1, 1½, and two hours thereafter. Cell integrity was assessed as
follows:
% LDH release. Lethal cell injury (membrane permeabilization)
was assessed by % LDH release [12] at the completion of cold
storage and at 1, 1½, and two hours of the 37°C incubation period
(N = 9 PTS preparations; paired aliquots DFO). Note that
DFO has previously been shown to have no effect on the
employed LDH assay [8].
Oxygen consumption rates. Oxygen consumption rates (Q02)
were used as a second index of the viable tubular cell mass (that
is, 002 directly correlates with the number of viable tubular cells
present). In brief, after completing the 37°C incubation, PTS
aliquots were placed in an oxygen monitoring system (0.6 ml
chamber; Diamond Electronics, Ann Arbor, MI, USA), and Q02s
were determined over five minutes using standard methodologies
(such as [13]). Five paired determinations (± DFO) were made.
Malondialdehyde (MDA) concentrations. As an index of PTS
lipid peroxidation, PTS suspension MDA concentrations were
determined immediately after PTS isolation, at the end of CS, and
at the end of the 37°C incubation period (N = 4 paired determi-
nations DFO). At the completion of each incubation period, 5
mM EDTA and 5 mM DFO were added to each sample to prevent
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Fig. 1. A. % LDH from tubules subjected to cold
storage (CS) in the absence of DFO (), in the
presence of DFO (S), and from tubules which
had not undergone CS (0). Values represent
B means I SCM. Tubules which underwent CS
without DFO manifested striking LDH release
during the 37°C incubation, the values far
exceeding those observed in tubules not
previously subjected to CS. Tubules subjected
to CS in the presence of DFO had LDH
release values which were essentially identical
to those observed with normal controls. This
implies that DFO had completely blocked CS-
induced injury. % LDH release at the end of
the CS/no re-warm period was also significantly
reduced by DFO treatment (P < 0.0005; paired
Student's t-test), indicating that the protection
was not merely a re-warming event. B. A
biochemical correlate of the DFO-induced
cytoprotection was a decrease in
_______________________
malondialdehyde (MDA) generation. The vast
majority of the lipid peroxidation developed
Baseline End 120 mm during the two hours 37°C incubation period
CS 37° C (end MDA values DFO: P < 0.001; paired
Student's t-test).
any lipid peroxidation beyond the experimentation period. The
samples were assayed by a thiobarbituric acid method [14].
Two controls for the above experiments were performed as
follows:
LDH release from normal PTS preparations. The goal of this
experiment was to demonstrate that freshly isolated PTS (no prior
CS) are far more viable than are PTS subjected to prior CS (for
example, to prove that CS causes tubular damage). Four freshly
isolated PTS preparations were incubated for two hours at 37°C
without prior CS. LDH release was then determined during a two
hours 37°C incubation, as noted above. The results were com-
pared to those observed in PTS with prior CS.
Effect of feroxamine on CS-induced PTS injury. The goal of this
experiment was to prove that DFO's protective effect was due to
iron chelation. To this end, four sets of PTS were subjected to the
standard CS protocol either under untreated conditions or in the
presence of iron saturated DFO (2 m'vi feroxamine). LDH release
and MDA concentrations were determined at the end of two
hours of 37°C incubation, as noted above.
Figure IA demonstrates that normal PTS (subjected to no CS)
released 18 1% LDH release by the completion of two hours of
37°C incubation (consistent with studies of this kind, such as [15]).
When PTS were first subjected to CS and then to this same two
hours 37°C incubation, 49 3% of LDH was released. This
clearly indicates that CS adversely impacts on cell viability, as
assessed during a two-hour 37°C incubation period. DFO addition
to PTS during CS was markedly cytoprotective, as demonstrated
by the following (Fig. 1): (1) The amount of LDH released by the
end of CS/no re-warm was reduced by 50% in the presence of
DFO (14 1% vs. 7 1%; P < 0.0005; paired Student's I-test);
(2) % LDH release at each point of the two-hour 37°C incubation
was dramatically lessened by DFO addition during CS; (3) %
LDH release after two hours of 37°C incubation was identical for
PTS subjected to CS with DFO versus PTS never subjected to CS
(18 1% for each); this implies that DFO had completely
eliminated CS-initiated cell death; (4) Q°2 were —P65% higher in
DFO versus non-DFO treated PTS after completing CS + two
hours of 37°C incubation (21.5 2.3 vs. 13.0 1.6 nmol 02
min' mg protein'; P < 0.001; paired Student's test); and (5)
the extent of MDA generation after completing two hours of 37°C
incubation was markedly reduced by DFO treatment during the
CS period (Fig. 1B). In data not depicted, feroxamine treatment
neither decreased LDH release (56 2% vs. 58 3%) nor MDA
generation (1.43 0.12 vs. 1.14 0.05 nmol/mg protein) (with vs.
without feroxamine, respectively; after 2 hr of 37°C incubation).
This indicates that DFO's protective effect was almost certainly
due to iron chelation.
In conclusion, this study indicates that iron chelation therapy
with DFO induces dramatic protection against CS-induced prox-
imal tubular cell injury, as tested with an isolated PTS model
system. Obviously, the in vivo relevance of these observations, and
whether the present results, obtained with mouse tubules, can be
extrapolated to renal tissues extracted from other animals remain
to be defined. However, regarding the latter issue, previous
studies from this laboratory strongly suggest that mouse tubules
are not uniquely vulnerable to iron mediated damage. For exam-
ple, when mouse or rat proximal tubules are subjected to intra-
cellular iron loading during in vivo myohemoglobinuria, compa-
rable degrees of lipid peroxidation and lethal cell injury develop in
subsequently isolated proximal tubules [16, 17]. We have also
documented that cultured human proximal tubular (HK-2) cells
are exquisitely sensitive to an exogenous myoglobin iron (0.25 /.LM)
challenge [18]. A recent study demonstrates that rabbit tubules
are also highly susceptible to intracellular iron loading [19].
Despite these observations with non-mouse kidney cells, the
critical question remains whether intact human kidneys will
maintain better structural integrity if they are subjected to CS in
the presence of an iron chelator. We believe that the dramatic
results of the present study suggest that this issue deserves future
investigation.
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